Skip to Main Content

Paper Details

H3K9 methylation drives resistance to androgen receptor-antagonist therapy in prostate cancer.
Proc Natl Acad Sci U S A
21
2022
H3K9, H3K9me3, RE, REs, androgen, androgen receptor, cellular signaling elements, double-stranded RNA, dsRNA, glucocorticoid receptor, interferon, patient, prostate cancer, retroelements, tumor
Author NameAffiliation
Ankur ChakravarthyPrincess Margaret Cancer Centre, University Health Network
Wei YuanDivision of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital
Michael BerkGenitourinary Malignancies Research Center, Lerner Research Institute, Cleveland Clinic
Johann S de BonoDivision of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital
Vladimir MakarovCenter for Immunotherapy and Precision Immuno-Oncology, Lerner Research Institute, Cleveland Clinic
Vladimir MakarovCenter for Immunotherapy and Precision Immuno-Oncology, Lerner Research Institute, Cleveland Clinic
  • 1 - 6

Datasets

Release 1.2